A new study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country's racial and ethnic ...
Mass General Brigham is announcing the spinout of AIwithCare, a company founded by researchers from the health system who developed an artificial intelligence (AI) screening tool that significantly ...
A UCR study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country’s racial and ethnic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback